{"result": "(\"entity\"<|>EFFECT OF TIMING OF PHARMACONUTRITION ADMINISTRATION<|>EVENT<|>A systematic review and meta-analysis examining the impact of the timing of immunonutrition administration on outcomes in elective surgery for gastrointestinal malignancies.)\n##\n(\"entity\"<|>META-ANALYSIS OF IMMUNE MODULATING NUTRIENTS<|>EVENT<|>A comprehensive analysis of the effects of combinations of immune modulating nutrients on outcomes in patients undergoing major open gastrointestinal surgery.)\n##\n(\"entity\"<|>PERIOPERATIVE IMMUNONUTRITION FOR GASTROINTESTINAL CANCER<|>EVENT<|>A systematic review of randomized controlled trials assessing the role of perioperative immunonutrition in patients with gastrointestinal cancer.)\n##\n(\"entity\"<|>EFFECT OF PREOPERATIVE ORAL IMMUNONUTRITION<|>EVENT<|>A randomized controlled trial investigating the impact of preoperative oral immunonutrition on complications and length of hospital stay after elective surgery for pancreatic cancer.)\n##\n(\"entity\"<|>EFFICACY OF PREOPERATIVE IMMUNONUTRITION<|>EVENT<|>A study evaluating the efficacy of preoperative immunonutrition in patients with locally advanced pancreatic cancer undergoing irreversible electroporation.)\n##\n(\"entity\"<|>APOPTOSIS IN LYMPHOCYTES OF PANCREATIC CANCER PATIENTS<|>EVENT<|>A study examining the influence of preoperative enteral immunonutrition and extensive surgery on apoptosis in lymphocytes of pancreatic cancer patients.)\n##\n(\"entity\"<|>COMPLIANCE WITH AND EFFECTS OF PREOPERATIVE IMMUNONUTRITION<|>EVENT<|>A study assessing the compliance and effects of preoperative immunonutrition in patients undergoing pancreaticoduodenectomy.)\n##\n(\"entity\"<|>SYSTEMIC IMMUNE DYSFUNCTION IN PANCREATIC CANCER PATIENTS<|>EVENT<|>A study investigating systemic immune dysfunction in patients with pancreatic cancer.)\n##\n(\"entity\"<|>DOWN-REGULATION OF THE ACUTE-PHASE RESPONSE<|>EVENT<|>A study on the down-regulation of the acute-phase response in pancreatic cancer cachexia patients receiving oral eicosapentaenoic acid.)\n##\n(\"entity\"<|>SCIENTIFIC RATIONALE FOR OPTIMIZING NUTRITIONAL SUPPORT IN CANCER<|>EVENT<|>A study discussing the scientific rationale for optimizing nutritional support in cancer patients.)\n##\n(\"entity\"<|>IMMUNOMODULATING ENTERAL NUTRITION IN MALNOURISHED SURGICAL PATIENTS<|>EVENT<|>A prospective, randomized, double-blind clinical trial on the effects of immunomodulating enteral nutrition in malnourished surgical patients.)\n##\n(\"relationship\"<|>EFFECT OF TIMING OF PHARMACONUTRITION ADMINISTRATION<|>JPEN J PARENTER ENTERAL NUTR<|>The systematic review on the timing of pharmaconutrition administration was published in JPEN J Parenter Enteral Nutr<|>8)\n##\n(\"relationship\"<|>META-ANALYSIS OF IMMUNE MODULATING NUTRIENTS<|>ANNALS OF SURGERY<|>The meta-analysis on immune modulating nutrients was published in Annals of Surgery<|>8)\n##\n(\"relationship\"<|>PERIOPERATIVE IMMUNONUTRITION FOR GASTROINTESTINAL CANCER<|>SURGICAL ONCOLOGY<|>The systematic review on perioperative immunonutrition for gastrointestinal cancer was published in Surgical Oncology<|>8)\n##\n(\"relationship\"<|>EFFECT OF PREOPERATIVE ORAL IMMUNONUTRITION<|>NUTRITION AND CANCER<|>The study on preoperative oral immunonutrition was published in Nutrition and Cancer<|>8)\n##\n(\"relationship\"<|>EFFICACY OF PREOPERATIVE IMMUNONUTRITION<|>EUROPEAN JOURNAL OF SURGICAL ONCOLOGY<|>The study on the efficacy of preoperative immunonutrition was published in the European Journal of Surgical Oncology<|>8)\n##\n(\"relationship\"<|>APOPTOSIS IN LYMPHOCYTES OF PANCREATIC CANCER PATIENTS<|>ARCHIVES OF IMMUNOLOGY AND THERAPY EXPERIMENTAL<|>The study on apoptosis in lymphocytes of pancreatic cancer patients was published in Archives of Immunology and Therapy Experimental<|>8)\n##\n(\"relationship\"<|>COMPLIANCE WITH AND EFFECTS OF PREOPERATIVE IMMUNONUTRITION<|>J HEPATOBILIARY PANCREAT SCI<|>The study on compliance with preoperative immunonutrition was published in J Hepatobiliary Pancreat Sci<|>8)\n##\n(\"relationship\"<|>SYSTEMIC IMMUNE DYSFUNCTION IN PANCREATIC CANCER PATIENTS<|>PANCREAS<|>The study on systemic immune dysfunction in pancreatic cancer patients was published in Pancreas<|>8)\n##\n(\"relationship\"<|>DOWN-REGULATION OF THE ACUTE-PHASE RESPONSE<|>CLINICAL SCIENCE<|>The study on down-regulation of the acute-phase response was published in Clinical Science<|>8)\n##\n(\"relationship\"<|>SCIENTIFIC RATIONALE FOR OPTIMIZING NUTRITIONAL SUPPORT IN CANCER<|>EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY<|>The study on optimizing nutritional support in cancer was published in the European Journal of Gastroenterology and Hepatology<|>8)\n##\n(\"relationship\"<|>IMMUNOMODULATING ENTERAL NUTRITION IN MALNOURISHED SURGICAL PATIENTS<|>CLINICAL NUTRITION<|>The study on immunomodulating enteral nutrition in malnourished surgical patients was published in Clinical Nutrition<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , Khan S, Memon MA.\n     Effect of timing of pharmaconutrition (immuno-\n     nutrition) administration on outcomes of elective\n     surgery for gastrointestinal malignancies: a syste-\n     matic review and meta-analysis. JPEN J Parenter\n     Enteral Nutr. 2014; 38:53-69.\n\n117. Marimuthu K, Varadhan KK, Ljungqvist O, Lobo\n     DN. A meta-analysis of the effect of combina-\n     tions of immune modulating nutrients on outco-\n     me in patients undergoing major open gastroin-\n     testinal surgery. Ann Surg. 2012; 255:1060-8.\n\n118. Zhang Y, Gu Y, Guo T, Li Y, Cai H. Perioperative\n     immunonutrition for gastrointestinal cancer: a\n     systematic review of randomized controlled\n     trials. Surg Oncol. 2012; 21:e87-95.\n\n119. Gade J, Levring T, Hillingsø J, Hansen CP, Ander-\n     sen JR. The Effect of Preoperative Oral Immunonu-\n     trition on Complications and Length of Hospital\n     Stay After Elective Surgery for Pancreatic Can-\n     cer--A Randomized Controlled Trial. Nutr Cancer.\n     2016; 68:225-33.\n\n120. Martin RC 2nd, Agle S, Schlegel M, Hayat T, Sco-\n     ggins CR, McMasters KM, et al. Efficacy of\n     preoperative immunonutrition in locally advan-\n     ced pancreatic cancer undergoing irreversible\n     electroporation (IRE). Eur J Surg Oncol. 2017. pii:\n     S0748-7983(17)30046-X.\n\n121. Słotwiński R, Olszewski W, Słodkowski M, Lech\n     G, Zaleska M, Kędziora S, et al. Apoptosis in lym-\n     phocytes of pancreatic cancer patients: influence\n     of preoperative enteral immunonutrition and ex-\n     tensive surgery. Arch Immunol Ther Exp (Warsz).\n     2011; 59:385-97.\n\n122. Shirakawa H, Kinoshita T, Gotohda N, Takahashi\n     S, Nakagohri T, Konishi M. Compliance with and\n     effects of preoperative immunonutrition in pa-\n     tients undergoing pancreaticoduodenectomy. J\n     Hepatobiliary Pancreat Sci. 2012; 19:249-58.\n\n123. Engineer DR, Garcia JM. Leptin in anorexia and\n     cachexia syndrome. Int J Peptides. 2012; 2012:\n     287457.\n\n124. Poch B, Lotspeich E, Ramadani M, Gansauge S,\n     Beger HG, Gansauge F. Systemic immune dys-\n     function in pancreatic cancer patients. Langen-\n     becks Arch Surg. 2007; 392:353-8.\n\n125. Wigmore SJ, Fearon KC, Maingay JP, Ross JA.\n     Down-regulation of the acute-phase response in\n     patients with pancreatic cancer cachexia receiving\n     oral eicosapentaenoic acid is mediated via su-\n     ppression of interleukin-6. Clin Sci (Lond). 1997;\n     92:215-21.\n---\n634    BLOQUE: NUTRICIÓN EN ONCOLOGÍA\n\n126. Skipworth RJ, Fearon KC. The scientific rationale for optimizing nutritional support in cancer. Eur J Gastroenterol Hepatol. 2007; 19: 371-7.\n\n127. Hamza N, Darwish A, O'Reilly DA, Denton J, Sheen AJ, Chang D, et al. Perioperative Enteral Immunonutrition Modulates Systemic and Mucosal Immunity and the Inflammatory Response in Patients With Periampullary Cancer Scheduled for Pancreaticoduodenectomy: A Randomized Clinical Trial. Pancreas. 2015; 44:41-52.\n\n128. Klek S, Sierzega M, Szybinski P, Szczepanek K, Scislo L, Walewska E, et al. The immunomodulating enteral nutrition in malnourished surgical patients - a prospective, randomized, double-blind clinical trial. Clin Nutr. 2011; 30:282-8.\n\n129. Suzuki D, Furukawa K, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, et al. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery. 2010; 148:573-81.\n\n130. Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC Jr. Lymphocyte subset responses to trauma and sepsis. J Trauma. 1993; 35:844-9.\n\n131. Braga M, Pecorelli N, Ariotti R, Capretti G, Greco M, Balzano G, et al. Enhanced Recovery After Surgery Pathway in Patients Undergoing Pancreaticoduodenectomy. World J Surg. 2014; 38:2960-6.\n\n132. Gerritsen A, Besselink MG, Gouma DJ, Steenhagen E\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>JPEN J PARENTER ENTERAL NUTR<|>ORGANIZATION<|>A journal that publishes research related to parenteral and enteral nutrition, including studies on immunonutrition and its effects on surgical outcomes.)\n##\n(\"entity\"<|>ANNALS OF SURGERY<|>ORGANIZATION<|>A medical journal that publishes articles on surgical practices and outcomes, including meta-analyses related to immunonutrition in surgery.)\n##\n(\"entity\"<|>SURGICAL ONCOLOGY<|>ORGANIZATION<|>A journal focused on the field of surgical oncology, publishing studies on cancer treatment and outcomes, including immunonutrition.)\n##\n(\"entity\"<|>NUTRITION AND CANCER<|>ORGANIZATION<|>A journal that explores the relationship between nutrition and cancer, including studies on immunonutrition and its effects on cancer patients.)\n##\n(\"entity\"<|>EUROPEAN JOURNAL OF SURGICAL ONCOLOGY<|>ORGANIZATION<|>A journal that publishes research on surgical oncology, including studies on preoperative immunonutrition and its impact on surgical outcomes.)\n##\n(\"entity\"<|>ARCHIVES OF IMMUNOLOGY AND THERAPY EXPERIMENTAL<|>ORGANIZATION<|>A journal that publishes research on immunology and its applications in therapy, including studies on immune responses in cancer patients.)\n##\n(\"entity\"<|>INTERNATIONAL JOURNAL OF PEPTIDES<|>ORGANIZATION<|>A journal that publishes research on peptides and their roles in various biological processes, including studies on leptin in cancer patients.)\n##\n(\"entity\"<|>CLINICAL SCIENCE<|>ORGANIZATION<|>A journal that publishes research on clinical and experimental medicine, including studies on the effects of nutrition on cancer cachexia.)\n##\n(\"entity\"<|>WORLD JOURNAL OF SURGERY<|>ORGANIZATION<|>A journal that publishes research on surgical techniques and outcomes, including studies on enhanced recovery after surgery pathways.)\n##\n(\"entity\"<|>PANCREAS<|>ORGANIZATION<|>A journal that focuses on research related to pancreatic diseases, including studies on immunonutrition in pancreatic cancer patients.)\n##\n(\"entity\"<|>KLEK S<|>PERSON<|>A researcher involved in studies on immunonutrition and its effects on surgical patients.)\n##\n(\"entity\"<|>MARIMUTHU K<|>PERSON<|>A researcher who conducted a meta-analysis on immune modulating nutrients in patients undergoing major gastrointestinal surgery.)\n##\n(\"entity\"<|>MARTIN RC 2ND<|>PERSON<|>A researcher who studied the efficacy of preoperative immunonutrition in patients with locally advanced pancreatic cancer.)\n##\n(\"entity\"<|>BRAGA M<|>PERSON<|>A researcher involved in studies on enhanced recovery after surgery pathways in patients undergoing pancreaticoduodenectomy.)\n##\n(\"entity\"<|>HAMZA N<|>PERSON<|>A researcher who conducted a clinical trial on perioperative enteral immunonutrition in patients with periampullary cancer.)\n##\n(\"entity\"<|>GERRITSEN A<|>PERSON<|>A researcher involved in studies related to surgical outcomes and immunonutrition.)\n##\n(\"relationship\"<|>MARIMUTHU K<|>ANNALS OF SURGERY<|>Marimuthu K conducted a meta-analysis published in Annals of Surgery on immune modulating nutrients in surgery<|>8)\n##\n(\"relationship\"<|>MARTIN RC 2ND<|>EUROPEAN JOURNAL OF SURGICAL ONCOLOGY<|>Martin RC 2nd's research on preoperative immunonutrition was published in the European Journal of Surgical Oncology<|>8)\n##\n(\"relationship\"<|>HAMZA N<|>PANCREAS<|>Hamza N's clinical trial on immunonutrition was published in the journal Pancreas<|>8)\n##\n(\"relationship\"<|>BRAGA M<|>WORLD JOURNAL OF SURGERY<|>Braga M's research on enhanced recovery after surgery was published in the World Journal of Surgery<|>8)\n##\n(\"relationship\"<|>KLEK S<|>NUTRITION AND CANCER<|>Klek S's research on immunomodulating enteral nutrition was published in Nutrition and Cancer<|>8)\n##\n(\"relationship\"<|>GERRITSEN A<|>ARCHIVES OF IMMUNOLOGY AND THERAPY EXPERIMENTAL<|>Gerritsen A's studies on immunology and surgery were published in Archives of Immunology and Therapy Experimental<|>8)\n<|COMPLETE|>"}]}